XML 105 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Notes to the Consolidated Statements of Operations - Revenue from contract with customers (Details) - EUR (€) € in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Notes to the Consolidated Statements of Operations
Total revenues	€ 53,758	€ 67,420	€ 102,990
Belgium | GSK
Notes to the Consolidated Statements of Operations
Total revenues	47,128	62,263	74,298
Switzerland | CRISPR
Notes to the Consolidated Statements of Operations
Total revenues	5,425	3,370	919
Netherlands | Genmab
Notes to the Consolidated Statements of Operations
Total revenues	1,197	€ 1,787	1,770
Germany | Boehringer Ingelheim
Notes to the Consolidated Statements of Operations
Total revenues			€ 26,003
Countries other than Belgium, Germany, Netherlands and Switzerland | Others
Notes to the Consolidated Statements of Operations
Total revenues	€ 8

X

- Definition

Represents of disclosure of notes to the consolidated financial statements.

+ References

No definition available.

+ Details

Name:	cvac_DisclosureOfNotesToConsolidatedFinancialStatementsLineItems
Namespace Prefix:	cvac_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_RevenueFromContractsWithCustomers
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	ifrs-full_GeographicalAreasAxis=country_BE
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MajorCustomersAxis=cvac_GlaxosmithklineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_GeographicalAreasAxis=country_CH
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MajorCustomersAxis=cvac_CrisprMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_GeographicalAreasAxis=country_NL
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MajorCustomersAxis=cvac_GenmabMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_GeographicalAreasAxis=country_DE
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MajorCustomersAxis=cvac_BoehringerIngelheimMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_GeographicalAreasAxis=cvac_CountriesOtherThanBelgiumGermanyNetherlandsAndSwitzerlandMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MajorCustomersAxis=cvac_OtherCustomersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: